Introducing Inizio: Ashfield and Huntsworth Unite Expertise to Form Strategic Partner
Ashfield and Huntsworth unite their full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services to create Inizio, a strategic partner to health and life science companies throughout the life cycle of their drug products.
Operating from 35 countries with a team of 10,000+ employees and an unparalleled number of strategic, scientific, medical and creative experts, Inizio connects the capabilities to support its clients with transformative go-to-market solutions across all therapeutic areas.
“The creation of Inizio is a direct response to the increasingly complex landscape our clients navigate in terms of clinical development, product launch and commercialization. Through Inizio they can access the specialist expertise and a partner that will help them to optimize the commercialization of their products.
Inizio launches with five specialist business units that provide a suite of capabilities from landscape assessment to loss of exclusivity: Inizio Advisory: Inizio Medical, Inizio MarComms, Inizio Engage, and Inizio Biotech.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
